Cargando…
Anti-IgE for the Treatment of Chronic Urticaria
Urticaria and angioedema are very common. Management of chronic urticaria subtypes, which usually persist for many years, is challenging. Recent years have demonstrated that targeting IgE with antibodies provides a safe and efficient treatment approach. Whilst several anti-IgE antibodies have been d...
Autores principales: | Wedi, Bettina, Traidl, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898214/ https://www.ncbi.nlm.nih.gov/pubmed/33628747 http://dx.doi.org/10.2147/ITT.S261416 |
Ejemplares similares
-
Prospective, monocentric, observational study of the long-term effectiveness of omalizumab in chronic urticaria
por: Traidl, Stephan, et al.
Publicado: (2023) -
Total IgE as a Marker for Chronic Spontaneous Urticaria
por: Altrichter, Sabine, et al.
Publicado: (2021) -
Anti-TPO IgE Autoantibody in Chronic Urticaria: Is It Clinically Relevant?
por: Ulambayar, Bastsetseg, et al.
Publicado: (2018) -
IgE-Related Chronic Diseases and Anti-IgE-Based Treatments
por: Navinés-Ferrer, Arnau, et al.
Publicado: (2016) -
IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab
por: Maronese, Carlo Alberto, et al.
Publicado: (2023)